Insider Trading Report: January 21, 2026 — 1 Purchase, 0 Sales Across 5 Companies
Overview
Insider trading activity filed on January 21, 2026, included 23 transactions totaling $28.0M across 5 unique tickers: CELH, CZWI, IMRX, PCH, and PESI. The most significant signal was a single purchase with no sales reported, highlighting potential insider confidence in at least one company.
Purchases are key indicators of optimism, as executives and directors use their own funds to buy shares. Here, the absence of sales further supports a lack of immediate concerns, though total activity included secondary transactions like awards, options, and tax payments.
News coverage was notable, with 22 articles across the tickers, led by CELH (10 articles), IMRX (7), and others, providing context for market interest.
Primary Insider Transactions (Purchases & Sales)
Purchases and sales represent the most meaningful insider signals, as they involve personal funds and can indicate confidence or caution. With 1 purchase and 0 sales, the focus is squarely on buying activity.
| Ticker | Insider | Title | Type | Value | Shares | Price | Market Cap | Filing Date |
|---|---|---|---|---|---|---|---|---|
| IMRX | Brakewood Harold Eugene | officer: Chief Business Office | 🟢 Purchase | $25K | 5,250 | $4.76 | N/A | 2026-01-21 |
This $25K purchase by IMRX's Chief Business Officer Brakewood Harold Eugene (5,250 shares at $4.76, company market cap $174M) signals strong insider confidence. As an officer buying with personal funds, it suggests belief in the company's prospects. No sales across any tickers is bullish, potentially indicating routine diversification was not a factor this period. IMRX ranks third in transaction value among the group.
Other Transactions (Awards, Options, etc.)
Secondary transactions included 9 others, 3 tax payments, 1 option exercise, and 9 awards, totaling the remaining activity. These are typically less significant than direct purchases or sales, often tied to compensation, exercises, or routine withholding.
| Ticker | Insider | Type | Value | Filing Date |
|---|---|---|---|---|
| PESI | Grondin Richard | Tax Payment | $24K | 2026-01-21 |
| PESI | Grondin Richard | Option Exercise | $24K | 2026-01-21 |
| CZWI | Bianchi Stephen M | Tax Payment | $12K | 2026-01-21 |
| CZWI | BROUCEK JAMES S | Tax Payment | $6K | 2026-01-21 |
| PCH | CREMERS ERIC J | Award | $0 | 2026-01-21 |
Notable clusters appeared in PCH (awards to multiple executives) and CELH (high-value other transactions by 10% owners totaling ~$27.9M), but these do not carry the same weight as primary buys or sells.
Recent News
[IMRX]
- No recent headlines available.
What This Means
Insider purchases, like the one in IMRX, often signal that those closest to the company see undervaluation or growth potential, especially from officers like the Chief Business Officer. The complete absence of sales amplifies this positive tone, as selling can sometimes reflect diversification, profit-taking, or concerns—but none occurred here across 23 filings.
That said, insider activity is just one data point in research. Transactions can stem from personal financial needs, planned sales under 10b5-1 rules, or compensation structures. Always cross-reference with fundamentals, earnings, and broader market trends.
Use this as a starting point for due diligence, not a buy/sell signal. Track patterns over time for stronger insights.
Independent, data-driven market research.
No hype. No promotions. Zero bias. Just experimental insights from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
Support the project by liking, sharing, or subscribing — it helps more readers discover these signals. 📊